Millard J - Search Results

1

Setting Preconception Care Priorities in Australia Using a Delphi Technique.

Boyle JA, Black K, Dorney E, Amor DJ, Brown L, Callander E, Camilleri R, Cheney K, Gordon A, Hammarberg K, Jeyapalan D, Leahy D, Millard J, Mills C, Musgrave L, Norman RJ, O'Brien C, Roach V, Skouteris H, Steel A, Walker S, Walker R. Boyle JA, et al. Among authors: millard j. Semin Reprod Med. 2022 Jul;40(3-04):214-226. doi: 10.1055/s-0042-1749683. Epub 2022 Jun 27. Semin Reprod Med. 2022. PMID: 35760312 Free article. Review.

2

Australian primary health care nurses’ knowledge, practice and attitudes relating to preconception care: learnings for service implementation.

Dorney E, Millard J, Hammarberg K, Griffin K, Gordon A, McGeechan K, Black KI. Dorney E, et al. Among authors: millard j. Aust J Prim Health. 2022 Feb;28(1):63-68. doi: 10.1071/PY21104. Aust J Prim Health. 2022. PMID: 34847988

3

Adult male with dysphagia.

Millard JT, Bloom AD. Millard JT, et al. J Am Coll Emerg Physicians Open. 2024 Apr 22;5(2):e13165. doi: 10.1002/emp2.13165. eCollection 2024 Apr. J Am Coll Emerg Physicians Open. 2024. PMID: 38741657 Free PMC article. No abstract available.

4

Rare case of divided phrenic nerve variation: a cadaveric case report.

Silveri OC, Dunemann G, Woo C, Gutman J, Palazzi J, Canestrino J, Luke B, Millard JA, Breiner M. Silveri OC, et al. Among authors: millard ja. Surg Radiol Anat. 2024 Apr 10. doi: 10.1007/s00276-024-03341-w. Online ahead of print. Surg Radiol Anat. 2024. PMID: 38597949

5

Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers.

Kirkpatrick DL, Evans C, Pestano LA, Millard J, Johnston M, Mick E, Schmidt WK. Kirkpatrick DL, et al. Among authors: millard j. Clin Transl Sci. 2024 Mar;17(3):e13765. doi: 10.1111/cts.13765. Clin Transl Sci. 2024. PMID: 38511523 Free PMC article. Clinical Trial.

6

Acetic Acid Enables Molecular Enumeration of Mycobacterium tuberculosis from Sputum and Eliminates the Need for a Biosafety Level 3 Laboratory.

Palekyte A, Morkowska A, Billington O, Morris-Jones S, Millard J, Marakalala MJ, Owolabi O, Sambou B, Zumla A, Sutherland JS, McHugh TD, Honeyborne I. Palekyte A, et al. Among authors: millard j. Clin Chem. 2024 Apr 3;70(4):642-652. doi: 10.1093/clinchem/hvae013. Clin Chem. 2024. PMID: 38479728

7

Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.

Nimmo C, Ortiz AT, Tan CCS, Pang J, Acman M, Millard J, Padayatchi N, Grant AD, O'Donnell M, Pym A, Brynildsrud OB, Eldholm V, Grandjean L, Didelot X, Balloux F, van Dorp L. Nimmo C, et al. Among authors: millard j. Genome Med. 2024 Feb 19;16(1):34. doi: 10.1186/s13073-024-01289-5. Genome Med. 2024. PMID: 38374151 Free PMC article.

8

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group; Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, Emberson JR, Stewart R, Prudon B, Uriel A, Green CA, Dhasmana DJ, Malein F, Majumdar J, Collini P, Shurmer J, Yates B, Baillie JK, Buch MH, Day J, Faust SN, Jaki T, Jeffery K, Juszczak E, Knight M, Lim WS, Montgomery A, Mumford A, Rowan K, Thwaites G, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. Nat Commun. 2024 Jan 31;15(1):924. doi: 10.1038/s41467-023-43644-x. Nat Commun. 2024. PMID: 38296965 Free PMC article. Clinical Trial.

9

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22. Lancet Child Adolesc Health. 2024. PMID: 38272046 Free article. Clinical Trial.

10

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.

CRyPTIC Consortium. CRyPTIC Consortium. Nat Commun. 2024 Jan 12;15(1):488. doi: 10.1038/s41467-023-44325-5. Nat Commun. 2024. PMID: 38216576 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page